By Keith Goldberg ( August 19, 2011, 6:46 PM EDT) -- Cadence Pharmaceuticals Inc. launched a patent infringement suit against generics makers Paddock Laboratories Inc. and Exela Pharma Sciences LLC in Delaware federal court on Thursday, seeking to block a generic version of Ofirmev, an injectable form of the pain reliever acetaminophen....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.